Irreversible electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
Authors
De Liguori Carino, NO'Reilly, D
Siriwardena, A
Valle, Juan W
Radhakrishna, Ganesh
Pihlak, Rille
McNamara, Mairéad G
Affiliation
Regional Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UKIssue Date
2018-10
Metadata
Show full item recordAbstract
The incidence of pancreatic ductal adenocarcinoma (PDAC) is rapidly increasing. Up to 30% of patients present with locally advanced disease and therefore are not candidates for surgery. Locally advanced pancreatic cancer (LAPC) is an emerging entity lacking in level III evidence-based recommendations for its treatment. Currently, systemic chemotherapy is the main treatment for LAPC. However, due to lack of response or disease progression, downsizing of the tumour, making it resectable is successful in only a small proportion of patients. Radiotherapy is often advocated to improve local disease control if there is stability following chemotherapy. Recently, Irreversible Electroporation (IRE), a novel non-thermal ablation technique, has been proposed for the treatment of LAPC.Citation
Irreversible electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment? 2018, 44(10): 1486-1493 Eur J Surg OncolJournal
European Journal of Surgical OncologyDOI
10.1016/j.ejso.2018.07.047PubMed ID
30146253Type
ArticleLanguage
enISSN
1532-2157ae974a485f413a2113503eed53cd6c53
10.1016/j.ejso.2018.07.047
Scopus Count
Collections
Related articles
- Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
- Authors: Marsanic P, Mellano A, Sottile A, De Simone M
- Issue date: 2017 Jul
- Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
- Authors: Oikonomou D, Karamouzis MV, Moris D, Dimitrokallis N, Papamichael D, Kountourakis P, Astras G, Davakis S, Papalampros A, Schizas D, Petrou AS, Felekouras E
- Issue date: 2021 Jul 1
- Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
- Authors: He C, Wang J, Zhang Y, Lin X, Li S
- Issue date: 2020 Apr
- Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
- Authors: He C, Wang J, Zhang Y, Cai Z, Lin X, Li S
- Issue date: 2020 Jul
- Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
- Authors: van Veldhuisen E, Vroomen LG, Ruarus AH, Derksen TC, Busch OR, de Jong MC, Kazemier G, Puijk RS, Sorgedrager NS, Vogel JA, Scheffer HJ, van Lienden KP, Wilmink JW, Besselink MG, Meijerink MR
- Issue date: 2020 Oct